Showing results (171-180 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
The relationship between symptomatology and treatment selection in metastatic castrate-resistant prostate cancerEric J Small, David F Penson, Oliver SartorClinical Advances in Hematology & Oncology : H&O|June 13, 2019
Bruton tyrosine kinase inhibitors for the treatment of mantle cell lymphoma: review of current evidence and future directionsDavid A Bond, Lapo Alinari, Kami MaddocksClinical Advances in Hematology & Oncology : H&O|October 12, 2021
Immunotherapy in esophagogastric cancerDavid H IlsonClinical Advances in Hematology & Oncology : H&O|March 15, 2022
Considerations in the management of younger patients with colorectal cancerJoleen M Hubbard, Cathy Eng, Chiara Cremolini, et al.Clinical Advances in Hematology & Oncology : H&O|January 13, 2023
Treatment landscape of advanced high-grade neuroendocrine neoplasmsSamee Zane Alheraki, Daniel R Almquist, Jason S Starr, et al.Clinical Advances in Hematology & Oncology : H&O|February 15, 2011
A new anticoagulant for a new era: review of recent data on dabigatran etexilateBishoy FaltasClinical Advances in Hematology & Oncology : H&O|February 18, 2011
Novel agents for the treatment of chronic lymphocytic leukemiaKarim Abou-Nassar, Jennifer R BrownClinical Advances in Hematology & Oncology : H&O|April 14, 2010
The rationale for the use of non-platinum chemotherapy doublets for metastatic and recurrent cervical carcinomaKrishnansu Sujata Tewari, Bradley J MonkClinical Advances in Hematology & Oncology : H&O|June 12, 2010
Clinical roundtable monograph: Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussionMyron S Czuczman, John P Leonard, Michael E WilliamsClinical Advances in Hematology & Oncology : H&O|June 13, 2009
Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancerCarolyn Kim, Arta M Monjazeb, Mohan Suntharalingam, et al.Pageof 68